Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions
In the study, color…
For clinically localized prostate cancer, urologists’ recommendations, rather than patients’ preferences, drive treatment decisions. Prospective longitudinal data from 257 men in Veterans Affairs hospitals showed that patients’ initial treatment preferences were not associated with receiving active treatment or surveillance, whereas urologists’ recommendations were strongly predictive of treatment received. Urologists’ recommendations were driven by medical factors (age and Gleason score) and rarely incorporated patients’ interest in sexual function.
Cont…
Bizonyítékszint: Klinikai vizsgálat. Formális klinikai vizsgálati eredmény.
Kapcsolódó jelek
- Apalutamide Treatment and Metastasis‑free Survival in Prostate Cancer
- The prostate cancer conundrum revisited: Treatment changes and prostate cancer mortality declines
- The contemporary management of prostate cancer
- Extracellular TROP2 Fragment Identified as a Potential Biomarker and Metastasis Driver
- Overall survival of prostate cancer patients treated with Lu‑177 PSMA 617 (Pluvicto®) in a multidisciplinary setting— a single center experience